U.S. markets close in 46 minutes
  • S&P 500

    3,845.99
    -7.08 (-0.18%)
     
  • Dow 30

    31,049.86
    -126.15 (-0.40%)
     
  • Nasdaq

    13,541.08
    +10.16 (+0.08%)
     
  • Russell 2000

    2,152.47
    +11.05 (+0.52%)
     
  • Crude Oil

    52.25
    -0.88 (-1.66%)
     
  • Gold

    1,855.80
    -10.10 (-0.54%)
     
  • Silver

    25.54
    -0.31 (-1.21%)
     
  • EUR/USD

    1.2170
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • GBP/USD

    1.3675
    -0.0055 (-0.40%)
     
  • USD/JPY

    103.8320
    +0.3270 (+0.32%)
     
  • BTC-USD

    33,483.71
    +2,999.96 (+9.84%)
     
  • CMC Crypto 200

    663.44
    +53.45 (+8.76%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,631.45
    -125.41 (-0.44%)
     

Teligent: 3Q Earnings Snapshot

·1 min read

BUENA, N.J. (AP) _ Teligent Inc. (TLGT) on Thursday reported a loss of $510,000 in its third quarter.

On a per-share basis, the Buena, New Jersey-based company said it had a loss of 8 cents. Losses, adjusted for one-time gains and costs, were 42 cents per share.

The specialty generic pharmaceutical company posted revenue of $14.3 million in the period.

For the current quarter ending in December, Teligent said it expects revenue in the range of $11 million to $12.5 million.

In the final minutes of trading on Thursday, the company's shares hit 73 cents. A year ago, they were trading at $4.26.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TLGT at https://www.zacks.com/ap/TLGT